tirzepatide and hfpef At #ACC25, Dr. Milton Packer colleagues present a new secondary analysis from the SUMMIT trial evaluating the effect of in patients with obesity, #HFpEF, and CKD. The trial demonstrated that # Tirzepatide for HFPEF and Obesity
Description
The preparation usually takes up to 7 business days
Consistency matters more than dose
The study found that tirzepatide had superior weight loss benefits compared to semaglutide, with an average weight loss of 20.2% of participants taking tirzepatide vs
According to the latest guidelines from the Swiss Society for Endocrinology and Diabetes (SSED) for T2DM treatment, the initial therapy should include GLP-1RAs or sodium-glucose transport protein 2 inhibitors (SGLT2is) with metformin
Note the time of onset, severity, and duration
